Skip to main navigation Skip to search Skip to main content

How to Predict Recurrence After Resection of Hepatocellular Carcinoma

  • Natalie Petruch
  • , Louisa Bolm
  • , Martina Nebbia
  • , Shahrzad Arya
  • , Marco Ventin
  • , Motaz Qadan
  • , Nahel Elias
  • , Jannis Duhn
  • , Dirk Rades
  • , Leigh A. Dageforde
  • , Kenneth T. Tanabe
  • , Joseph Franses
  • , Vikram Deshpande
  • , Ulrich F. Wellner
  • , Tobias Keck
  • , Onofrio Catalano
  • , Cristina R. Ferrone*
  • *Corresponding author for this work
  • Harvard University
  • University of Kiel
  • Cedars-Sinai Medical Center
  • Beth Israel Medical Center

Abstract

Background/Aim: Predictors of recurrence following resection of hepatocellular carcinoma (HCC) are not fully established. This study investigated potential risk factors and prognostic scores for this situation. Patients and Methods: In 297 patients undergoing resection of HCC between 2000 and 2021, risk scores and potential additional risk factors for intrahepatic and extrahepatic recurrence were assessed. Results: Median overall survival was 48.4 months, median time to recurrence 25.1 months. The Alpha-Fetoprotein (AFP)-score differentiated between low and high-risk groups (21.8 vs. 8.3 months, p=0.001), as did the Risk Estimation of Tumor Recurrence After Transplant (RETREAT)-score (16 vs. 9 months, p=0.004) and the Clinical Risk Score (CRS) (14.9 vs. 3.9 months, p=0.002). Advanced T-stage, multiple lesions, and vessel infiltration were significantly associated with any type of recurrence, advanced T-stage, and multiple lesions with intrahepatic recurrence. Conclusion: Predictors of recurrence following resection of HCC were identified. Prognostic scores traditionally used for patients receiving liver transplantation (AFP-score, RETREAT-score, CRS) were predictive also of recurrence after resection of HCC.

Original languageEnglish
JournalAnticancer Research
Volume45
Issue number1
Pages (from-to)189-199
Number of pages11
ISSN0250-7005
DOIs
Publication statusPublished - 01.2025

Funding

FundersFunder number
Deutsche ForschungsgemeinschaftBO-5659

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    DFG Research Classification Scheme

    • 2.22-14 Hematology, Oncology
    • 2.22-25 General and Visceral Surgery

    Fingerprint

    Dive into the research topics of 'How to Predict Recurrence After Resection of Hepatocellular Carcinoma'. Together they form a unique fingerprint.

    Cite this